NCT04880434 · Interventional trial
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)
Overall registry status Completed
Phase 2
Conditions Relapsed/Refractory Mantle Cell Lymphoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory